Interleukin-12-based immunotherapy against rat 9L glioma

Neurosurgery

Volumn 42, Issue 4, 1998, Pages 850-857

  Jean, Walter C ^a   Spellman, Stephen R ^a   Wallenfriedman, Margaret A ^a   Hall, Walter A ^a   Low, Walter C ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Cytokine; Glioma; Immunotherapy; Interleukin 12

Indexed keywords

RECOMBINANT INTERLEUKIN 12; SODIUM CHLORIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTATION; ARTICLE; CANCER IMMUNOTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; DOSE RESPONSE; FEMALE; GLIOMA; GLIOSARCOMA; IRRADIATION; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; TUMOR CELL; TUMOR VOLUME;

ANIMALS; BRAIN NEOPLASMS; FEMALE; GLIOMA; GRAFT REJECTION; HYPERSENSITIVITY, DELAYED; IMMUNOLOGIC MEMORY; IMMUNOTHERAPY; INTERLEUKIN-12; NEOPLASM TRANSPLANTATION; RATS; RATS, INBRED F344; TUMOR CELLS, CULTURED;

EID: 0031957449     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006123-199804000-00097     Document Type: Article

References (20)

1. Abbas AK, Lichtman AH, Pober JS: Cellular and Molecular Immunology. Philadelphia, W. B. Saunders Co, 1994, p. 263.
2. Brunda MJ, Luistro L, Rumennik L, Wright RB, Dvorozniak M, Aglione A, Wigginton JM, Wiltrout R, Hendrzak JA, Palleroni AV: Antitumor activity of interleukin-12 in preclinical models. Cancer Chemother Pharmacol 38[Suppl]:S16-S20, 1996.
3. Brunda MJ, Luistro L, Warrier RR, Wright RB, Hubbard BR, Murphy M, Wolf SF, Gately MK: Antitumor and antimetastatic activity of interleukin-12 against murine tumors. J Exp Med 178: 1223-1230, 1993.
4. Fontana A, Hengartner H, de Tribolet N, Weber, E: Glioblastoma cells release interleukin-1 and factors inhibiting interleukin-2-mediated effects. J Immunol 132:1837-1844, 1984.
5. Fontana A, Kristensen F, Dubs R, Gemsa D, Weber E: Production of prostaglandin E and an interleukin-1-like factor by cultured astrocytes and C6 glioma cells. J Immunol 129:2413-2419, 1982.
6. Fujiwara H, Hamaoka T: Antitumor and antimetastatic effects of interleukin-12. Cancer Chemother Pharmacol 38[Suppl]:S22-S26, 1996.
7. Germann T, Rude E: Interleukin-12. Int Arch Allergy Immunol 108:103-112, 1995.
8. Hsieh C-S, Macatonia SE, Tripp CE, Wolf SF, O'Gara A, Murphy KM: Development of Th-1 CD4 T cells through IL-12 produced by Listeria-induced macrophages. Science 260:547-549, 1993.
9. Lieschke GJ, Rao PK, Gately MK, Mulligan RC: Bioactive murine and human interleukin-12 fusion proteins which retain antitumor activity in vivo. Nature Biotechnol 15:35-40, 1997.
10. Nastala CL, Edington HD, McKinney TG, Tahara H, Nalesnik MA, Brunda MJ, Gately MK, Wolf SF, Schreiber RD, Storkus WJ, Lotze MT: Recombinant IL-12 administration induces tumor regression in association with IFN-γ production. J Immunol 153:1697-1706, 1994.
11. Noguchi Y, Richards EC, Chen Y-T, Old LJ: Influence of interleukin-12 on p53 peptide vaccination against established meth A sarcoma. Proc Natl Acad Sci U S A 92:2219-2223, 1995.
12. Rakhmilevich AL, Turner J, Ford MJ, McCabe D, Sun WH, Sondel PM, Grota K Yang N-S: Gene gun-mediated skin transfection with interleukin-12 gene results in regression of established primary and metastatic murine tumors. Proc Natl Acad Sci U S A 93:6291-6296, 1996.
13. Roszman T, Elliott L, Brooks W: Modulation of T-cell function by gliomas. Immunol Today 12:370-374, 1991.
14. Schoenhaut DS, Chua AO, Wolitzky AG, Quinn PM, Dwyer CM, McComas W, Familletti PC, Gately MK, Gubler U: Cloning and expression of murine IL-12. J Immunol 148:3433-3440, 1992.
15. Siemann DW, Lord EM, Keng PC, Wheeler KT: Cell subpopulation dispersed from solid tumours and separated by centrifugal elutriation. Br J Cancer 44:100-108, 1981.
16. Tahara H, Lotze MT: Antitumor effects of interleukin-12 (IL-12): Application for the immunotherapy and gene therapy of cancer. Gene Ther 2:96-106, 1995.
17. Tsung K, Meko JB, Peplinski GR, Tsung YL, Norton JA: IL-12 induces T helper 1-directed antitumor response. J Immunol 158: 3359-3365, 1997.
18. Urbani F, Maleci A, La Sala A, Lande R, Ausiello CM: Defective expression of Interferon-γ, granulocyte-macrophage colony stimulating factor, tumor necrosis factor α, and interleukin-6 in activated peripheral blood lymphocytes from glioma patients. J Interferon Cytokine Res 15:421-429, 1995.
19. Wallenfriedman MA, Graupman P, Lee G, Conrad J, Chiang L, Wen DYK, Hall WA, Low WC: Immunotherapy of glioblastoma with granulocyte/macrophage colony stimulating factor (GMCSF) based vaccines. Presented at the 2nd Biennial Brain Tumor Satellite Symposium of the Congress of Neurological Surgeons, Montreal, Canada, October 3-4, 1996.
20. Zitvogel L, Couderc B, Mayordomo JI, Robbins PD, Lotze MT, Storkus WJ: II-12-engineered dendritic cells serve as effective tumor vaccine adjuvants in vivo. Ann N Y Acad Sci 795:284-293, 1996.